Randall Kaye - Nov 19, 2024 Form 4 Insider Report for Longboard Pharmaceuticals, Inc. (LBPH)

Role
CMO
Signature
/s/ Andrew J. Cronauer, Attorney-In-Fact
Stock symbol
LBPH
Transactions as of
Nov 19, 2024
Transactions value $
$183,324
Form type
4
Date filed
11/19/2024, 08:13 PM
Previous filing
Oct 29, 2024
Next filing
Dec 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LBPH Common Stock Options Exercise $183K +30.6K +170.5% $6.00 48.5K Nov 19, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LBPH Stock Option (Right to Buy) Options Exercise $0 -30.6K -14.8% $0.00 176K Nov 19, 2024 Common Stock 30.6K $6.00 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a cash exercise of vested stock options without a subsequent sale of the underlying shares of common stock.
F2 Includes the 17,920 restricted stock units (RSUs) that were granted on February 8, 2024, and reported in a Form 4 filed on February 9, 2024. The RSUs will vest in four equal annual installments commencing on February 8, 2025, and the shares underlying the RSUs will be issued upon vesting and release of the RSUs.
F3 1/4th of the shares subject to the stock option vest on March 21, 2023, and the remaining shares vest in 36 equal monthly installments thereafter.